•  
  •  
 

Problems and perspectives in pharmaceutics and drug discovery

Abstract

The article presents data from a clinical trial to study the efficacy and tolerability of local production montelukast drugs. The clinical efficacy of the drugs was evaluated in points to improve clinical and laboratory data. The study showed positive dynamics of clinical and laboratory parameters in all children who received Montelukast drugs. Studies have shown that taking montelukast drugs leads to a decrease in the level of cys-LT, IgE in children with bronchial asthma.

First Page

85

Last Page

89

References

1. Nenasheva N.V. Rol antileykotrienovix preparatov v dostijenii kontrolya bronxialnoy astmi - Meditsinskiy sovet - 2018 18- s.44-552. Romanova I.S., Kojanova I.N., Gavrilenko L.N. i dr. Rol antileykotrienovogo preparata montelukasta v lechenii detey s bronxialnoy astmoy. - Meditsinskie novosti - 2012 2 - s.62-693. Selimzyanova S.R., Vishnyova E.A., Promislova E.A. Printsipi diagnostiki i terapii bronxialnoy astmi u detey na sovremennom etape: obzor obnovleniy GINA 2014-20154. Anandan C, Nurmatov U, van Schayck OCP, Sheikh A. Is the prevalence of asthma declining? Systematic review of epidemiological studies. Allergy,2010, 65: 152-167.5. GINA 2015. www.ginasthma.org.6. Thomas AE. Platts-Mills. The Allergy Epidemics: 1870-2010. J Allergy Clin Immunol, 2015, 136(1): 3-13.

Share

COinS